Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

5.07
Delayed Data
As of May 26
 +0.21 / +4.32%
Today’s Change
2.78
Today|||52-Week Range
5.79
+44.44%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close4.86
Today’s open4.89
Day’s range4.89 - 5.08
Volume2,899
Average volume (3 months)33,923
Market cap$59.2M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-55.21%
Earnings growth (this year)+19.80%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales85.49
Price/Book5.33

Competitors

 Today’s
change
Today’s
% change
IPCIIntellipharmaceutics...-0.01-0.51%
MEIPMEI Pharma Inc+0.15+7.61%
EIGREiger BioPharmaceuti...0.000.00%
PTNPalatin Technologies...-0.01-2.63%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 17, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$467.0K
Annual profit (last year)-$17.0M
Net profit margin-3,630.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Yohai Stenzler
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts